Multi-dimensional measurement of antibody-mediated heterosubtypic immunity to influenza

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Wang, Jiong ^a   Hilchey, Shannon P ^a   Hyrien, Ollivier ^a   Huertas, Nelson ^a   Perry, Sheldon ^a   Ramanunninair, Manojkumar ^b   Bucher, Doris ^b   Zand, Martin S ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; RECOMBINANT INFLUENZA VIRUS HEMAGGLUTININ; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; IMMUNOGLOBULIN; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANALYTICAL PARAMETERS; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGENIC CARTOGRAPHY; ARTICLE; BINDING AFFINITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FERRET; FLUORESCENT MULTIPLEX ASSAY; HEMAGGLUTINATION INHIBITION TEST; HETEROSUBTYPIC IMMUNITY; HUMAN; IMMUNITY; IMMUNOASSAY; IMMUNOLOGICAL PROCEDURES; IMMUNOREACTIVITY; INFLUENZA; INFLUENZA A; INFLUENZA A (A/CALIFORNIA/07/2009); INFLUENZA A (A/HONG KONG/1/1968); INFLUENZA A (A/PERTH/16/2009); INFLUENZA A (A/PORT CHALMERS/1/1973); INFLUENZA A (A/VICTORIA/210/2009); INFLUENZA A (A/VICTORIA/361/2011); INFLUENZA B; INFLUENZA B (B/BRISBANE/60/2008); INFLUENZA B (B/MASSACHUSETTS/2/2012); INFLUENZA B (B/WISCONSIN/1/2010); INFLUENZA VACCINATION; INTERASSAY VARIABILITY; INTRAASSAY VARIABILITY; LIMIT OF QUANTITATION; MEASUREMENT ACCURACY; MOLECULAR CLONING; NONHUMAN; PHYLOGENETIC TREE; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REPRODUCIBILITY; SEASONAL INFLUENZA; VALIDATION PROCESS; VIRUS STRAIN; BLOOD; IMMUNOLOGY; PHYLOGENY;

MUSTELA;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNOGLOBULINS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PHYLOGENY;

EID: 84939212624     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129858     Document Type: Article

References (51)

1. Committee on infectious d. Recommendations for prevention and control of influenza in children, 2013-2014. Pediatrics. 2013;132(4):e1089-104. doi: 10.1542/peds.2013-2377 PMID: 23999962.
2. Members of the Western Pacific Region Global Influenza Surveillance Response S, Dwyer D, Barr I, Hurt A, Kelso A, Reading P, et al. Seasonal influenza vaccine policies, recommendations and use in the World Health Organization's Western Pacific Region. Western Pacific surveillance and response journal: WPSAR. 2013;4(3):51-9. doi: 10.5365/WPSAR.2013.4.1.009 PMID: 24319615; PubMed Central PMCID: PMC3851365.
3. Ohmit SE, Petrie JG, Cross RT, Johnson E, Monto AS. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. J Infect Dis. 2011;204(12):1879-85. doi: 10.1093/infdis/jir661 PMID: 21998477.
4. Epstein SL, Lo CY, Misplon JA, Lawson CM, Hendrickson BA, Max EE, et al. Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice. J Immunol. 1997;158(3):1222-30. PMID: 9013963.
5. Nguyen HH, van Ginkel FW, Vu HL, McGhee JR, Mestecky J. Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes. J Infect Dis. 2001;183(3):368-76. doi: 10.1086/318084 PMID: 11133367.
6. de Jong JC, Beyer WE, Palache AM, Rimmelzwaan GF, Osterhaus AD. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A (H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol. 2000;61(1):94-9. Epub 2000/04/04. PMID: 10745239.
7. Stanekova Z, Adkins I, Kosova M, Janulikova J, Sebo P, Vareckova E. Heterosubtypic protection against influenza A induced by adenylate cyclase toxoids delivering conserved HA2 subunit of hemagglutinin. Antiviral research. 2013;97(1):24-35. doi: 10.1016/j.antiviral.2012.09.008 PMID: 23036818.
8. McVernon J, Laurie K, Barr I, Kelso A, Skeljo M, Nolan T. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study. Influenza Other Respir Viruses. 2011;5(1):7-11. Epub 2010/12/09. doi: 10.1111/j.1750-2659.2010.00172.x PMID: 21138535.
9. Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, Salimi N, et al. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(48):20365-70. Epub 2009/11/18. doi: 10.1073/pnas.0911580106 PMID: 19918065; PubMed Central PMCID: PMC2777968.
10. Barr IG, McCauley J, Cox N, Daniels R, Engelhardt OG, Fukuda K, et al. Epidemiological, antigenic and genetic characteristics of seasonal influenza A (H1N1), A (H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season. Vaccine. 2010;28(5):1156-67. doi: 10.1016/j.vaccine.2009.11.043 PMID: 20004635.
11. Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, Throsby M, et al. Antibody recognition of a highly conserved influenza virus epitope. Science. 2009;324(5924):246-51. doi: 10.1126/science. 1171491 PMID: 19251591; PubMed Central PMCID: PMC2758658.
12. Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M, Yu W, et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science. 2011;333(6044):843-50. doi: 10.1126/science. 1204839 PMID: 21737702; PubMed Central PMCID: PMC3210727.
13. Burlington DB, Clements ML, Meiklejohn G, Phelan M, Murphy BR. Hemagglutinin-specific antibody responses in immunoglobulin G, A, and M isotypes as measured by enzyme-linked immunosorbent assay after primary or secondary infection of humans with influenza A virus. Infection and immunity. 1983;41(2):540-5. PMID: 6874068; PubMed Central PMCID: PMC264675.
14. Burlington DB, Wright PF, van Wyke KL, Phelan MA, Mayner RE, Murphy BR. Development of subtypespecific and heterosubtypic antibodies to the influenza A virus hemagglutinin after primary infection in children. Journal of clinical microbiology. 1985;21(5):847-9. PMID: 3839001; PubMed Central PMCID: PMC271797.
15. Remarque EJ, de Bruijn IA, Boersma WJ, Masurel N, Ligthart GJ. Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay. J Med Virol. 1998;55(1):82-7. PMID: 9580890.
16. Medeiros R, Escriou N, Naffakh N, Manuguerra JC, van der Werf S. Hemagglutinin residues of recent human A (H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes. Virology. 2001;289(1):74-85. Epub 2001/10/17. doi: 10.1006/viro.2001.1121 PMID: 11601919.
17. Ellebedy AH, Krammer F, Li GM, Miller MS, Chiu C, Wrammert J, et al. Induction of broadly crossreactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans. Proc Natl Acad Sci U S A. 2014;111(36):13133-8. doi: 10.1073/pnas.1414070111 PMID: 25157133.
18. Sangster MY, Baer J, Santiago FW, Fitzgerald T, Ilyushina NA, Sundararajan A, et al. B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination. Clinical and vaccine immunology: CVI. 2013;20(6):867-76. doi: 10.1128/CVI.00735-12 PMID: 23576673; PubMed Central PMCID: PMC3675965.
19. Tharakaraman K, Subramanian V, Cain D, Sasisekharan V, Sasisekharan R. Broadly neutralizing influenza hemagglutinin stem-specific antibody CR8020 targets residues that are prone to escape due to host selection pressure. Cell host & microbe. 2014;15(5):644-51. doi: 10.1016/j.chom.2014.04.009 PMID: 24832457.
20. Wyrzucki A, Dreyfus C, Kohler I, Steck M, Wilson IA, Hangartner L. Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody. J Virol. 2014;88(12):7083-92. doi: 10.1128/JVI.00178-14 PMID: 24719426; PubMed Central PMCID: PMC4054347.
21. Murphy BR, Phelan MA, Nelson DL, Yarchoan R, Tierney EL, Alling DW, et al. Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses. J Clin Microbiol. 1981;13(3):554-60. PMID: 7240388; PubMed Central PMCID: PMC273830.
22. van de Water C, van Dura EA, van der Stap JG, Brands R, Boersma WJ. Rapid in vitro micro-cytotoxicity tests for the detection and quantitation of neutralizing antibodies to both viruses and toxins. J Immunol Methods. 1993;166(2):157-64. PMID: 8288870.
23. Fouchier RA, Smith DJ. Use of antigenic cartography in vaccine seed strain selection. Avian diseases. 2010;54(1 Suppl):220-3. PMID: 20521635.
24. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, et al. Mapping the antigenic and genetic evolution of influenza virus. Science. 2004;305(5682):371-6. Epub 2004/06/26. doi: 10.1126/science.1097211 PMID: 15218094.
25. de Jong JC, Smith DJ, Lapedes AS, Donatelli I, Campitelli L, Barigazzi G, et al. Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe. J Virol. 2007;81(8):4315-22. Epub 2007/02/09. doi: 10.1128/JVI.02458-06 PMID: 17287258; PubMed Central PMCID: PMC1866135.
26. Bedford T, Suchard MA, Lemey P, Dudas G, Gregory V, Hay AJ, et al. Integrating influenza antigenic dynamics with molecular evolution. eLife. 2014;3:e01914. doi: 10.7554/eLife.01914 PMID: 24497547; PubMed Central PMCID: PMC3909918.
27. Cai Z, Zhang T, Wan XF. A computational framework for influenza antigenic cartography. PLoS computational biology. 2010;6(10):e1000949. doi: 10.1371/journal.pcbi.1000949 PMID: 20949097; PubMed Central PMCID: PMC2951339.
28. Cai Z, Zhang T, Wan XF. Concepts and applications for influenza antigenic cartography. Influenza Other Respir Viruses. 2011;5 Suppl 1:204-7. PMID: 21761589; PubMed Central PMCID: PMC3208348.
29. Henn AD, Wu S, Qiu X, Ruda M, Stover M, Yang H, et al. High-resolution temporal response patterns to influenza vaccine reveal a distinct human plasma cell gene signature. Sci Rep. 2013;3:2327. Epub 2013/08/01. doi: 10.1038/srep02327 PMID: 23900141; PubMed Central PMCID: PMC3728595.
30. Santiago FW, Lambert Emo K, Fitzgerald T, Treanor JJ, Topham DJ. Antigenic and immunogenic properties of recombinant hemagglutinin proteins from H1N1 A/Brisbane/59/07 and B/Florida/04/06 when produced in various protein expression systems. Vaccine. 2012;30(31):4606-16. Epub 2012/05/23. doi: 10.1016/j.vaccine.2012.05.005 PMID: 22609035; PubMed Central PMCID: PMC3379008.
31. Wang K, Holtz KM, Anderson K, Chubet R, Mahmoud W, Cox MM. Expression and purification of an influenza hemagglutinin-one step closer to a recombinant protein-based influenza vaccine. Vaccine. 2006;24(12):2176-85. doi: 10.1016/j.vaccine.2005.11.005 PMID: 16310896.
32. Lal G, Balmer P, Stanford E, Martin S, Warrington R, Borrow R. Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes. J Immunol Methods. 2005;296(1-2):135-47. Epub 2005/02/01. doi: 10.1016/j.jim.2004.11.006 PMID: 15680158.
33. Quataert SA, Kirch CS, Wiedl LJ, Phipps DC, Strohmeyer S, Cimino CO, et al. Assignment of weightbased antibody units to a human antipneumococcal standard reference serum, lot 89-S. Clin Diagn Lab Immunol. 1995;2(5):590-7. Epub 1995/09/01. PMID: 8548539; PubMed Central PMCID: PMC170204.
34. Squires RB, Noronha J, Hunt V, Garcia-Sastre A, Macken C, Baumgarth N, et al. Influenza research database: an integrated bioinformatics resource for influenza research and surveillance. Influenza Other Respir Viruses. 2012;6(6):404-16. doi: 10.1111/j.1750-2659.2011.00331.x PMID: 22260278; PubMed Central PMCID: PMC3345175.
35. Watson DS, Reddy SM, Brahmakshatriya V, Lupiani B. A multiplexed immunoassay for detection of antibodies against avian influenza virus. J Immunol Methods. 2009;340(2):123-31. doi: 10.1016/j.jim. 2008.10.007 PMID: 19000692.
36. Wiersma EJ, Collins C, Fazel S, Shulman MJ. Structural and functional analysis of J chain-deficient IgM. J Immunol. 1998;160(12):5979-89. PMID: 9637512.
37. Muramatsu M, Yoshida R, Yokoyama A, Miyamoto H, Kajihara M, Maruyama J, et al. Comparison of antiviral activity between IgA and IgG specific to influenza virus hemagglutinin: increased potential of IgA for heterosubtypic immunity. PLoS One. 2014;9(1):e85582. doi: 10.1371/journal.pone.0085582 PMID: 24465606; PubMed Central PMCID: PMC3895000.
38. Chowdhury MY, Seo SK, Moon HJ, Talactac MR, Kim JH, Park ME, et al. Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice. Virology journal. 2014;11:21. doi: 10.1186/1743-422X-11-21 PMID: 24502341; PubMed Central PMCID: PMC3923897.
39. Bodewes R, Kreijtz JH, Hillaire ML, Geelhoed-Mieras MM, Fouchier RA, Osterhaus AD, et al. Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice. The Journal of general virology. 2010;91(Pt 7):1743-53. doi: 10.1099/vir.0.020784-0 PMID: 20335492.
40. Bodewes R, Kreijtz JH, Baas C, Geelhoed-Mieras MM, de Mutsert G, van Amerongen G, et al. Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus. PLoS One. 2009;4(5):e5538. doi: 10.1371/journal. pone.0005538 PMID: 19440239; PubMed Central PMCID: PMC2678248.
41. Fonville JM, Wilks SH, James SL, Fox A, Ventresca M, Aban M, et al. Antibody landscapes after influenza virus infection or vaccination. Science. 2014;346(6212):996-1000. doi: 10.1126/science. 1256427 PMID: 25414313; PubMed Central PMCID: PMC4246172.
42. Margine I, Hai R, Albrecht RA, Obermoser G, Harrod AC, Banchereau J, et al. H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice. J Virol. 2013;87(8):4728-37. doi: 10.1128/JVI.03509-12 PMID: 23408625; PubMed Central PMCID: PMC3624338.
43. Margine I, Krammer F, Hai R, Heaton NS, Tan GS, Andrews SA, et al. Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses. J Virol. 2013;87(19):10435-46. doi: 10.1128/JVI.01715-13 PMID: 23903831; PubMed Central PMCID: PMC3807421.
44. Barnett JL, Yang J, Cai Z, Zhang T, Wan XF. AntigenMap 3D: an online antigenic cartography resource. Bioinformatics. 2012;28(9):1292-3. doi: 10.1093/bioinformatics/bts105 PMID: 22399675; PubMed Central PMCID: PMC3338011.
45. Lewis NS, Anderson TK, Kitikoon P, Skepner E, Burke DF, Vincent AL. Substitutions near the hemagglutinin receptor-binding site determine the antigenic evolution of influenza A H3N2 viruses in U. S. swine. J Virol. 2014;88(9):4752-63. doi: 10.1128/JVI.03805-13 PMID: 24522915; PubMed Central PMCID: PMC3993788.
46. Sun H, Yang J, Zhang T, Long LP, Jia K, Yang G, et al. Using sequence data to infer the antigenicity of influenza virus. mBio. 2013;4(4). doi: 10.1128/mBio.00230-13 PMID: 23820391; PubMed Central PMCID: PMC3705446.
47. Daly JM, Elton D. Potential of a sequence-based antigenic distance measure to indicate equine influenza vaccine strain efficacy. Vaccine. 2013;31(51):6043-5. doi: 10.1016/j.vaccine.2013.06.070 PMID: 23831320.
48. Nayak JL, Richards KA, Yang H, Treanor JJ, Sant AJ. Effect of Influenza A (H5N1) Vaccine Prepandemic Priming on CD4+ T-Cell Responses. J Infect Dis. 2014. doi: 10.1093/infdis/jiu616 PMID: 25378637.
49. Gall A, Hoffmann B, Harder T, Grund C, Hoper D, Beer M. Design and validation of a microarray for detection, hemagglutinin subtyping, and pathotyping of avian influenza viruses. J Clin Microbiol. 2009;47(2):327-34. doi: 10.1128/JCM.01330-08 PMID: 19052173; PubMed Central PMCID: PMC2643657.
50. Price JV, Jarrell JA, Furman D, Kattah NH, Newell E, Dekker CL, et al. Characterization of influenza vaccine immunogenicity using influenza antigen microarrays. PLoS One. 2013;8(5):e64555. doi: 10. 1371/journal.pone.0064555 PMID: 23734205; PubMed Central PMCID: PMC3667171.
51. Desbien AL, Van Hoeven N, Reed SJ, Casey AC, Laurance JD, Baldwin SL, et al. Development of a high density hemagglutinin protein microarray to determine the breadth of influenza antibody responses. BioTechniques. 2013;54(6):345-8. doi: 10.2144/000114041 PMID: 23750544.